LIGAND PHARMACEUTICALS INC (LGND) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Asset disposition
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Notes have priced
Inv. presentation

LIGAND PHARMACEUTICALS INC (LGND)

Create: Alert

All | News | Filings

Date Filed	Type	Description
02/09/2023	SC 13D/A	LIGAND PHARMACEUTICALS INC reports a 7.9% stake in Viking Therapeutics, Inc.
08/28/2020	SC 13D/A	LIGAND PHARMACEUTICALS INC reports a 9.9% stake in Viking Therapeutics, Inc.
11/13/2018	SC 13D/A	LIGAND PHARMACEUTICALS INC reports a 10.4% stake in VIKING THERAPEUTICS, INC.
05/24/2016	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
04/15/2016	SC 13D/A	Viking Therapeutics, Inc. reports a 39.8% stake in VIKING THERAPEUTICS, INC.
09/06/2011	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
08/24/2011	SC 13D/A	LIGAND PHARMACEUTICALS INC reports a 7.8% stake in Ligand Pharmaceuticals Incorporated
02/10/2010	SC 13D/A	Form SC 13D - General statement of acquisition of beneficial ownership [amend]
01/28/2010	SC 13D/A	LIGAND PHARMACEUTICALS INC reports a 100% stake in METABASIS THERAPEUTICS, INC.
12/30/2009	SC 13D/A	LIGAND PHARMACEUTICALS INC reports a 100% stake in NEUROGEN CORPORATION

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy